{
  "main_header": {
    "sid": 1241686,
    "name": "Monopar Therapeutics, Inc.",
    "stock_name": "Monopar Therapeutics, Inc.",
    "full_name": "Monopar Therapeutics, Inc.",
    "name_url": "stocks-analysis/monopar-therapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "79.47",
    "chg": 3.53,
    "chgp": "4.65%",
    "dir": 1,
    "prev_price": "75.94",
    "mcapval": "255.93",
    "mcap": "",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US61023L1089",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "310.18 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/monopar-therapeutics-inc-1241686-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Monopar Therapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-monopar-therapeutics-inc-technically-bullish-or-bearish-3547530",
        "imagepath": "",
        "date": "2025-09-20 19:57:36",
        "description": "As of 11 September 2025, the technical trend for Monopar Therapeutics, Inc. has changed from mildly bullish to bullish. The current technical stance is bullish, with strong indicators supporting this view. The MACD is bullish on both the weekly and monthly time frames, and Bollinger Bands also indicate bullish conditions for both periods. Daily moving averages are bullish, while the KST shows bullish signals on both weekly and monthly charts. However, the Dow Theory indicates a mildly bullish stance on both time frames, and the OBV is mildly bullish weekly but mildly bearish monthly. Overall, the bullish indicators outweigh the bearish ones. There is no available multi-period return data for comparison with the S&P 500...."
      },
      {
        "title": "Monopar Therapeutics Hits New 52-Week High at $68.18",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/monopar-therapeutics-hits-new-52-week-high-at-6818-3531540",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/MonoparTherapeu_priceRelatedfactors_3531540.png",
        "date": "2025-09-18 13:23:05",
        "description": "Monopar Therapeutics, Inc. has achieved a new 52-week high of USD 68.18, significantly up from its low of USD 3.90. With a market capitalization of USD 256 million, the company operates in the Pharmaceuticals & Biotechnology sector, facing challenges reflected in its financial metrics."
      },
      {
        "title": "Monopar Therapeutics Stock Soars to New 52-Week High of $58.94",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/monopar-therapeutics-stock-soars-to-new-52-week-high-of-5894-3525934",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/MonoparTherapeu_priceRelatedfactors_3525934.png",
        "date": "2025-09-17 15:20:50",
        "description": "Monopar Therapeutics, Inc. has achieved a new 52-week high, reflecting a significant increase from its previous low. With a market capitalization of USD 256 million, the company operates at a loss and has a unique financial structure, highlighting its evolving position in the biotechnology sector."
      },
      {
        "title": "Monopar Therapeutics Hits New 52-Week High of $54.54",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/monopar-therapeutics-hits-new-52-week-high-of-5454-3519638",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/MonoparTherapeu_priceRelatedfactors_3519638.png",
        "date": "2025-09-16 11:30:50",
        "description": "Monopar Therapeutics, Inc. has achieved a new 52-week high, reflecting a significant increase from its previous low. Operating in the Pharmaceuticals & Biotechnology sector, the company has a market capitalization of USD 256 million, though it faces challenges with negative financial metrics and a premium price-to-book ratio."
      }
    ],
    "total": 7,
    "sid": "1241686",
    "stock_news_url": "https://www.marketsmojo.com/news/monopar-therapeutics-inc-1241686"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Monopar Therapeutics, Inc. technically bullish or bearish?

2025-09-20 19:57:36

As of 11 September 2025, the technical trend for Monopar Therapeutics, Inc. has changed from mildly bullish to bullish. The current technical stance is bullish, with strong indicators supporting this view. The MACD is bullish on both the weekly and monthly time frames, and Bollinger Bands also indicate bullish conditions for both periods. Daily moving averages are bullish, while the KST shows bullish signals on both weekly and monthly charts. However, the Dow Theory indicates a mildly bullish stance on both time frames, and the OBV is mildly bullish weekly but mildly bearish monthly. Overall, the bullish indicators outweigh the bearish ones. There is no available multi-period return data for comparison with the S&P 500....

Read More

Monopar Therapeutics Hits New 52-Week High at $68.18

2025-09-18 13:23:05

Monopar Therapeutics, Inc. has achieved a new 52-week high of USD 68.18, significantly up from its low of USD 3.90. With a market capitalization of USD 256 million, the company operates in the Pharmaceuticals & Biotechnology sector, facing challenges reflected in its financial metrics.

Read More

Monopar Therapeutics Stock Soars to New 52-Week High of $58.94

2025-09-17 15:20:50

Monopar Therapeutics, Inc. has achieved a new 52-week high, reflecting a significant increase from its previous low. With a market capitalization of USD 256 million, the company operates at a loss and has a unique financial structure, highlighting its evolving position in the biotechnology sector.

Read More

Monopar Therapeutics Hits New 52-Week High of $54.54

2025-09-16 11:30:50

Monopar Therapeutics, Inc. has achieved a new 52-week high, reflecting a significant increase from its previous low. Operating in the Pharmaceuticals & Biotechnology sector, the company has a market capitalization of USD 256 million, though it faces challenges with negative financial metrics and a premium price-to-book ratio.

Read More

View All News